Analysts remain divided on Gogo Inc.'s trajectory as the in-flight connectivity provider navigates its 5G network launch against a backdrop of strategic shifts and evolving satellite technology debates.
Investment firm Maxim Group reaffirms its Buy rating and $1.50 price target for Strive Inc., following the company's transformative acquisition of Semler Scientific, which positions it as a major corporate Bitcoin holder and expands its healthcare tech footprint.
Michigan's Attorney General has formally demanded the return of state funds from Gotion Inc., a Chinese battery manufacturer, following the collapse of its planned $2.4 billion facility. The move highlights growing tensions over foreign investment in U.S. strategic industries.
DexCom Inc. (DXCM) has released preliminary Q4 figures that exceeded expectations and provided robust long-term guidance, reinforcing its position as a favored pick among analysts and hedge funds in the medical devices sector.
A wave of updated price targets from Wall Street analysts is prompting investors to reassess Diana Shipping Inc. The shifting forecasts reflect changing views on dry bulk shipping fundamentals and the company's strategic position, moving the stock's story beyond recent quarters.
Popular, Inc. (BPOP) shares have rallied following robust 2025 results, driven by higher net interest income, EPS growth, and aggressive shareholder returns via dividends and buybacks. With the stock up nearly 20% in 90 days, investors are weighing whether its current valuation still offers an entry point.
Regional airline SkyWest, Inc. has locked in multi-year contract extensions with United Airlines and Delta Air Lines for its Embraer E175 aircraft, providing a stable foundation for growth and improved financial visibility. The agreements solidify the company's fleet strategy and partnership with Embraer amid a competitive landscape.
Fermi Inc. is confronting multiple class action lawsuits alleging it misled investors about tenant demand and funding risks for its flagship AI data center project, Project Matador. The legal challenges emerge as the company navigates a high-stakes, capital-intensive build-out in a competitive sector.
Rogers Communications Inc. reported robust fourth-quarter 2025 results, with revenue reaching C$6.17 billion and net income of C$743 million. The company's strategic pivot into sports and media, fueled by the MLSE acquisition and content partnerships, is emerging as a significant growth driver, challenging its traditional telecom narrative.
Karat Packaging Inc. (NASDAQ: KRT) showcases a consistent 18% return on capital employed, outperforming its industry. Yet, as capital investment grows, analysts debate whether the sustainable packaging firm can accelerate value creation for shareholders seeking multi-bagger potential.
BrightSpire Capital, Inc. (BRSP) finds itself predominantly in the hands of institutional investors, a vote of confidence that brings both stability and potential volatility. As major funds like Vanguard and BlackRock hold significant shares, the stock's trajectory is closely tied to their moves.
Despite a challenging mortgage landscape and specific credit headwinds, Hilltop Holdings Inc. (HTH) reported a 46% surge in annual net income for 2025, buoyed by a steepening yield curve and disciplined cost management across its banking, lending, and securities divisions.
United Natural Foods, Inc. launches a landmark grant program across all 50 U.S. states and Canada to celebrate its 50th year, even as its stock performance presents a mixed picture for value-focused investors.
Quarterhill Inc. (TSE:QTRH) shareholders have endured a punishing five-year period, with the stock's value plummeting nearly 70%. Despite modest revenue growth, the market's verdict has been harsh, raising questions about the company's path to profitability and the perils of long-term bets in turbulent sectors.
Erasca Inc. (ERAS) sees its price target raised from $5 to $12 by Guggenheim, following promising clinical data for its lead oncology candidates and updated financial models. The move comes amid a series of positive analyst revisions for the clinical-stage biopharma firm.
Clinical-stage biopharma Alumis Inc. (ALMS) is gaining significant Wall Street attention after its lead drug candidate, envudeucitinib, successfully met all endpoints in key Phase 3 trials for plaque psoriasis, prompting multiple analyst upgrades and optimistic price targets.
Innodata Inc. (NASDAQ: INOD), a data engineering and AI services firm, has been awarded a place on a critical U.S. Missile Defense Agency contract vehicle, positioning it for future task orders in defense technology development and fueling analyst optimism for its 2026 growth trajectory.
T-Mobile US Inc. (NASDAQ:TMUS) ranks among the most promising QQQ stocks according to hedge funds. On January 21, Benchmark reaffirmed its Buy rating on T-Mobile US Inc. (NASDAQ:TMUS) with a $295 price target, classifying the telecom provider as a “2026 Benchmark Best Idea.” The firm remains confident that T-Mobile’s network strengths and potential for expanded […]
Analyst firm Compass Point reiterates its Buy rating on Invesco Mortgage Capital Inc. (IVR), increasing its price target to $9.50, citing attractive mortgage spreads as a key catalyst for the REIT's potential book value growth.
In its latest investor letter, David Einhorn's Greenlight Capital revealed it has sold its stake in HP Inc., redirecting capital towards AI-focused investments it believes offer superior risk-reward profiles amid the tech giant's recent struggles.
